Sales and Marketing

Showing 15 posts of 11528 posts found.

Novartis buys dry eye treatment Xiidra in deal worth $5.3 billion

May 9, 2019 Business Services, Medical Communications, Sales and Marketing Novartis, Shire, Takeda, debt, pharma, xiidra

Japanese multinational Takeda Pharmaceutical has agreed to sell its dry eye drug Xiidra to Swiss firm Novartis in a deal …

Sanofi’s Dupixent approved in Europe for severe asthma maintenance

May 9, 2019 Sales and Marketing Dupixent, EU, Europe, Sanofi, asthma, pharma

Sanofi has revealed that its interleukin-4 and interleukin-13 (IL-4 and IL-13) inhibitor Dupixent (dupilumab) has been awarded marketing approval by …

Mohammed Dar becomes third MedImmune exec to join Immunocore

May 7, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

MedImmune’s Vice President of Clincial Development Oncology, Mohammed Dar has joined British biotech Immunocore as the company’s new CMO. Dar …

ABPI names Novartis’ Haseeb Ahmad as new President

May 7, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Novartis, appointment, pharma

The Association of the British Pharmaceutical Industry (ABPI) has revealed the appointment of a new President: Haseeb Ahmad will assume …

Gilead’s CFO and Executive Vice President to depart in 2020

May 7, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, appointment, pharma

Gilead has announced that Robin Washington, the company’s Senior Vice President and Chief Financial Officer of more than a decade, …

Will mobile phones save the NHS?

May 7, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, UK, feature, mhealth, mobile health, pharma

The NHS is sick. According to politicians and NHS chiefs, the cure involves a strong dose of mHealth. Louis Goss …

Astellas and Cytokinetics’ reldesemtiv falls short at Phase 2 in ALS

May 7, 2019 Manufacturing and Production, Sales and Marketing Astellas, als, amyotrophic lateral sclerosis, cytokinetics, pharma

Cytokinetics has announced at the American Academy of Neurology (AAN) that its fast skeletal muscle troponin activator (FSTA) reldesemtiv fell …

Lundbeck acquire Abide Therapeutics in deal worth $400 million

May 7, 2019 Manufacturing and Production, Sales and Marketing Abide Therapeutics, Lundbeck, endocannabinoid system, neuropathic pain, tourette's

Danish firm Lundbeck has agreed to acquire San Diego-based biotech Abide Therapeutics as part of a deal worth $400 million. …

GW Pharma’s Epidiolex scores in rare childhood onset epilepsy Phase 3 trial

May 7, 2019 Manufacturing and Production, Sales and Marketing CBD, Epidiolex, GW Pharma, cannabidiol, cannabis, epilepsy, tsc

GW Pharma’s Epidiolex has shown positive Phase 3 trial results for the fifth time in a row, after meeting primary …

FDA approves first two drugs for transthyretin amyloid cardiomyopathy

May 7, 2019 Manufacturing and Production, Sales and Marketing FDA, Pfizer, US, Vyndamax, Vyndaqel, pharma

The FDA has approved its first two therapies for the treatment of cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM), …

Health Secretary Matt Hancock says he will not rule out ‘compulsory vaccination’

May 7, 2019 Manufacturing and Production, Sales and Marketing Matt Hancock, infectious diseases, pharma, public health, vaccines

Health Secretary Matt Hancock has said he would not rule out ‘compulsory vaccination,’ as he argued that those spreading anti-vaccine …

ABPI names Novartis’ Haseeb Ahmad as new President

May 3, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Novartis, appointment, pharma

The Association of the British Pharmaceutical Industry (ABPI) has revealed the appointment of a new President: Haseeb Ahmad will assume …

Top Ten most popular articles on Pharmafile.com this week!

May 3, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, Gilead, autism, dementia, opioids, pharma

This week was marked by the failure of two Phase 3 trials after both Eli Lilly and Gilead suffered from …

Sanofi’s Dengvaxia becomes first FDA-approved dengue vaccine, but with caveats…

May 2, 2019 Sales and Marketing FDA, Sanofi, dengue, dengvaxia, pharma

Sanofi has announced that the FDA has granted authorisation to its tetravalent vaccine Dengvaxia for prevention of dengue disease originating …

FDA refuses to review Nabriva’s injectable antibiotic for urinary tract infections

May 1, 2019 Research and Development, Sales and Marketing Contepo, Nabriva, pharma, urinary tract infections

Biopharma firm Nabriva Therapeutics has revealed that its antibiotic Contepo (fosfomycin) has been rejected for review by the FDA as …
The Gateway to Local Adoption Series

Latest content